Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Myovant On Path To Women’s Health Leadership, CEO Says

Executive Summary

CEO Lynn Seely talked during a fireside chat at the BIO CEO & Investor meeting about her company’s strategy to build a new women’s health company and even best big pharma rivals.

Advertisement

Related Content

Myovant CEO Says Buoyant IPO Reflects High Interest In Women's Health
Pfizer’s $14bn Medivation Buyout Shows How Far Pharma Will Go In Oncology
Takeda Continues To Shed Pipeline Assets In Roivant Deal

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC098246

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel